SCYNEXIS, Inc. (SCYX) Dividend History

SCYNEXIS, Inc. is a biopharmaceutical company focused on developing and commercializing innovative antifungal therapies. It is known for its oral antifungal drug, Brexafemme (ibrexafungerp), which is approved for the treatment of certain fungal infections. The company emphasizes research and development to address unmet medical needs in fungal diseases and expand its portfolio of antifungal agents.

1 Evertrust Plaza, Jersey City, NJ, 07302-6548
Phone: 201-884-5485
Website: https://www.scynexis.com

Dividend History

SCYNEXIS, Inc. currently does not pay dividends

Company News

  • A leading company engaged DelveInsight to conduct a comprehensive study on the myopia market, including prevalence, treatment patterns, and market forecasts across the APAC region. DelveInsight's analysis provided strategic insights to help the client optimize its market entry and differentiation strategies.

    GlobeNewswire Inc.
    Featured Companies: EYEN
  • Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter. Resources Connection posted quarterly adjusted earnings of 28 cents per share, beating market estimates of 18 cents per share. The company’s quarterly sales came in at $163.1 million versus expectations of $161.936 million. Resources Connection shares jumped 6.5% to $14.58 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Jeffs' Brands Ltd(NASDAQ: JFBR) gained 60.6% to $5.06 in pre-market trading after surging 25% on Wednesday. Jeffs' Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology. Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 41% to $0.1984 in pre-market trading after falling over 11% on Wednesday. Kintara Therapeutics, last month, announced a review of strategic alternatives focused on maximizing stockholder value. The Arena Group Holdings, Inc. (NYSE: AREN) shares rose 26.8% to $2.65 in pre-market trading after falling over 9% on Wednesday. Arena Group Board, last month, terminated employment of CEO Ross Levinsohn. 180 Life Sciences Corp. (NASDAQ: ATNF) shares gained 24.4% to $0.2550 in pre-market ...

    Benzinga
    Featured Companies: ABVC ADN AREN ATNF BROG CALM EJH JFBR MTC RGP SLS
  • Verve Therapeutics (VERV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

    Zacks Investment Research
    Featured Companies: VERV
  • Use these tips to identify penny stocks opportunities The post Penny Stocks: Technical Approach to Finding Opportunities  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
  • Michael Burry cut his public positions from 22 securities to just six. He added three new stocks, including Lockheed Martin. Read what investors should know.

    Seeking Alpha
    Featured Companies: CVS CXW DNOW GEO LMT
Page data last updated 07/23/2025 23:55:54 UTC